| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |